Literature DB >> 25497245

High-sensitivity cardiac troponin T and the risk of incident atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study.

Kristian B Filion1, Sunil K Agarwal2, Christie M Ballantyne3, Maria Eberg4, Ron C Hoogeveen3, Rachel R Huxley5, Laura R Loehr6, Vijay Nambi7, Elsayed Z Soliman8, Alvaro Alonso9.   

Abstract

INTRODUCTION: Structural changes in the heart are known risk factors for atrial fibrillation (AF). An association between high-sensitivity cardiac troponin T (hs-cTnT), a marker of myocardial cell damage measured with a high-sensitivity assay, and the risk of AF could have implications for AF risk stratification.
OBJECTIVE: To estimate the association between hs-cTnT and the risk of incident AF in the ARIC study, a prospective cohort of middle-aged adults from 4 US communities.
METHODS: Study included 10,584 participants (mean age 62.7 years) free of AF in 1996 to 1998 and followed through 2008. Atrial fibrillation was defined using International Classification of Diseases codes from hospitalizations and death certificates. Participants with undetectable hs-cTnT levels (58%) were assigned the lower limit of measurement (5 ng/L). Net reclassification improvement was used to examine the discriminative ability of hs-cTnT for 10-year AF risk prediction (categories: <5%, 5%-15%, and >15%).
RESULTS: A total of 920 incident AF cases were observed for 109,227 person-years. After adjustment, a 1-SD difference in ln(hs-cTnT) was associated with a hazard ratio of 1.16 (95% CI 1.10-1.23). Compared with those with undetectable levels, participants with hs-cTnT ≥14 ng/L had a hazard ratio of 1.78 (95% CI 1.43-2.24). Addition of hs-cTnT to known AF predictors did not increase the c statistic appreciably (0.756 vs 0.758) or improve risk stratification (net reclassification improvement 0.4%, 95% CI -1.4% to 2.3%).
CONCLUSIONS: High-sensitivity cTnT level is associated with an increased incidence rate of AF but did not improve risk stratification.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25497245      PMCID: PMC4429290          DOI: 10.1016/j.ahj.2014.10.005

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  25 in total

1.  Interpreting incremental value of markers added to risk prediction models.

Authors:  Michael J Pencina; Ralph B D'Agostino; Karol M Pencina; A Cecile J W Janssens; Philip Greenland
Journal:  Am J Epidemiol       Date:  2012-08-08       Impact factor: 4.897

2.  High-sensitive cardiac troponin T and its relations to cardiovascular risk factors, morbidity, and mortality in elderly men.

Authors:  Kai M Eggers; Jinan Al-Shakarchi; Lars Berglund; Bertil Lindahl; Agneta Siegbahn; Lars Wallentin; Björn Zethelius
Journal:  Am Heart J       Date:  2013-08-13       Impact factor: 4.749

3.  Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I and incident atrial fibrillation.

Authors:  Michiel Rienstra; Xiaoyan Yin; Martin G Larson; João D Fontes; Jared W Magnani; David D McManus; Elizabeth L McCabe; Erin E Coglianese; Michael Amponsah; Jennifer E Ho; James L Januzzi; Kai C Wollert; Michael G Fradley; Ramachandran S Vasan; Patrick T Ellinor; Thomas J Wang; Emelia J Benjamin
Journal:  Am Heart J       Date:  2013-10-17       Impact factor: 4.749

4.  Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience.

Authors:  A D White; A R Folsom; L E Chambless; A R Sharret; K Yang; D Conwill; M Higgins; O D Williams; H A Tyroler
Journal:  J Clin Epidemiol       Date:  1996-02       Impact factor: 6.437

5.  Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study).

Authors:  Laura R Loehr; Wayne D Rosamond; Patricia P Chang; Aaron R Folsom; Lloyd E Chambless
Journal:  Am J Cardiol       Date:  2008-02-14       Impact factor: 2.778

6.  B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.

Authors:  Moritz F Sinner; Katherine A Stepas; Carlee B Moser; Bouwe P Krijthe; Thor Aspelund; Nona Sotoodehnia; João D Fontes; A Cecile J W Janssens; Richard A Kronmal; Jared W Magnani; Jacqueline C Witteman; Alanna M Chamberlain; Steven A Lubitz; Renate B Schnabel; Ramachandran S Vasan; Thomas J Wang; Sunil K Agarwal; David D McManus; Oscar H Franco; Xiaoyan Yin; Martin G Larson; Gregory L Burke; Lenore J Launer; Albert Hofman; Daniel Levy; John S Gottdiener; Stefan Kääb; David Couper; Tamara B Harris; Brad C Astor; Christie M Ballantyne; Ron C Hoogeveen; Andrew E Arai; Elsayed Z Soliman; Patrick T Ellinor; Bruno H C Stricker; Vilmundur Gudnason; Susan R Heckbert; Michael J Pencina; Emelia J Benjamin; Alvaro Alonso
Journal:  Europace       Date:  2014-07-18       Impact factor: 5.214

7.  High-sensitivity cardiac troponin T levels and secondary events in outpatients with coronary heart disease from the Heart and Soul Study.

Authors:  Alexis L Beatty; Ivy A Ku; Robert H Christenson; Christopher R DeFilippi; Nelson B Schiller; Mary A Whooley
Journal:  JAMA Intern Med       Date:  2013-05-13       Impact factor: 21.873

8.  Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities study.

Authors:  Razvan T Dadu; Myriam Fornage; Salim S Virani; Vijay Nambi; Ron C Hoogeveen; Eric Boerwinkle; Alvaro Alonso; Rebecca F Gottesman; Thomas H Mosley; Christie M Ballantyne
Journal:  Stroke       Date:  2013-05-09       Impact factor: 7.914

9.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

10.  Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium.

Authors:  Alvaro Alonso; Bouwe P Krijthe; Thor Aspelund; Katherine A Stepas; Michael J Pencina; Carlee B Moser; Moritz F Sinner; Nona Sotoodehnia; João D Fontes; A Cecile J W Janssens; Richard A Kronmal; Jared W Magnani; Jacqueline C Witteman; Alanna M Chamberlain; Steven A Lubitz; Renate B Schnabel; Sunil K Agarwal; David D McManus; Patrick T Ellinor; Martin G Larson; Gregory L Burke; Lenore J Launer; Albert Hofman; Daniel Levy; John S Gottdiener; Stefan Kääb; David Couper; Tamara B Harris; Elsayed Z Soliman; Bruno H C Stricker; Vilmundur Gudnason; Susan R Heckbert; Emelia J Benjamin
Journal:  J Am Heart Assoc       Date:  2013-03-18       Impact factor: 5.501

View more
  18 in total

1.  High-Sensitivity Cardiac Troponin, Natriuretic Peptide, and Long-Term Risk of Acute Kidney Injury: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Junichi Ishigami; Yuhree Kim; Yingying Sang; Steven P Menez; Morgan E Grams; Hicham Skali; Amil M Shah; Ron C Hoogeveen; Elizabeth Selvin; Scott D Solomon; Christie M Ballantyne; Josef Coresh; Kunihiro Matsushita
Journal:  Clin Chem       Date:  2021-01-08       Impact factor: 8.327

2.  Serial measures of cardiac troponin T levels by a highly sensitive assay and incident atrial fibrillation in a prospective cohort of ambulatory older adults.

Authors:  Ayman A Hussein; Traci M Bartz; John S Gottdiener; Nona Sotoodehnia; Susan R Heckbert; Donald Lloyd-Jones; Jorge R Kizer; Robert Christenson; Oussama Wazni; Christopher deFilippi
Journal:  Heart Rhythm       Date:  2015-01-17       Impact factor: 6.343

Review 3.  The Atrium in Atrial Fibrillation - A Clinical Review on How to Manage Atrial Fibrotic Substrates.

Authors:  Pedro Silva Cunha; Sérgio Laranjo; Jordi Heijman; Mário Martins Oliveira
Journal:  Front Cardiovasc Med       Date:  2022-07-04

4.  Longitudinal increases in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism.

Authors:  A R Folsom; P L Lutsey; S R Heckbert; K Poudel; S Basu; R C Hoogeveen; M Cushman; C M Ballantyne
Journal:  J Thromb Haemost       Date:  2018-08-11       Impact factor: 5.824

5.  High-sensitivity troponin and the risk of atrial fibrillation in chronic kidney disease: Results from the Chronic Renal Insufficiency Cohort Study.

Authors:  Scott E Janus; Jamal Hajjari; Sadeer Al-Kindi
Journal:  Heart Rhythm       Date:  2019-08-14       Impact factor: 6.343

Review 6.  High-Sensitivity Troponin as a Biomarker in Heart Rhythm Disease.

Authors:  Cian P McCarthy; Omair Yousuf; Alvaro Alonso; Elizabeth Selvin; Hugh Calkins; John W McEvoy
Journal:  Am J Cardiol       Date:  2017-02-09       Impact factor: 2.778

Review 7.  Predicting Atrial Fibrillation and Its Complications.

Authors:  Alvaro Alonso; Faye L Norby
Journal:  Circ J       Date:  2016-03-24       Impact factor: 2.993

8.  Association of circulating cardiac biomarkers with electrocardiographic abnormalities in chronic kidney disease.

Authors:  Alexander J Kula; Ronit Katz; Leila R Zelnick; Elsayed Soliman; Alan Go; Michael Shlipak; Rajat Deo; Bonnie Ky; Ian DeBoer; Amanda Anderson; Rob Christenson; Stephen L Seliger; Chris Defilippi; Harold I Feldman; Myles Wolf; John Kusek; Tariq Shafi; Jiang He; Nisha Bansal
Journal:  Nephrol Dial Transplant       Date:  2021-12-02       Impact factor: 5.992

9.  Association of Elevated High Sensitivity Cardiac Troponin T(hs-cTnT) Levels with Hemorrhagic Transformation and 3-Month Mortality in Acute Ischemic Stroke Patients with Rheumatic Heart Disease in China.

Authors:  Junfeng Liu; Deren Wang; Yao Xiong; Bian Liu; Zilong Hao; Wendan Tao; Ming Liu
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

10.  High sensitivity troponin T and I reflect mitral annular plane systolic excursion being assessed by cardiac magnetic resonance imaging.

Authors:  Michèle Natale; Michael Behnes; Seung-Hyun Kim; Julia Hoffmann; Nadine Reckord; Ursula Hoffmann; Johannes Budjan; Siegfried Lang; Martin Borggrefe; Theano Papavassiliu; Thomas Bertsch; Ibrahim Akin
Journal:  Eur J Med Res       Date:  2017-10-04       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.